Kirkland & Ellis advised Clearhaven Partners LP on the deal. Clearhaven Partners LP (Clearhaven) announced the closing of its sophomore fund, Clearhaven Fund II, L.P. (Fund II),...
Clearhaven Fund II’s Closing at $580 Million
Angeles Equity Partners’ Closing of $540 Million Fund II
Kirkland & Ellis advised Angeles Equity Partners LLC in the deal. Angeles Equity Partners LLC announced the final closing of Angeles Equity Partners II, L.P. and its...
Kuvare’s Launch of Kindley Re Ltd.
Sidley Austin LLP, working closely with Appleby, represented Kuvare Holdings. Kirkland & Ellis advised Davidson Kempner Capital Management LP and Kindley Re Ltd. on the deal...
Panacea Venture’s $276 Million Fundraising
Kirkland & Ellis has advised Panacea Venture on the deal. Panacea Venture announced its second USD healthcare fund, which comprises of two vehicles, Panacea Venture Healthcare...
TPG Real Estate Partners IV’s $6.8 Billion Fundraising
Kirkland & Ellis advised TPG Real Estate on the deal. TPG Real Estate (TPGRE), the dedicated real estate platform of global alternative asset firm TPG, announced...
Thompson Street Capital Partners VI’s $1.5 Billion Fundraising
Kirkland & Ellis advised Thompson Street Capital Partners on the deal. Thompson Street Capital Partners (TSCP), a private equity firm focused on investing in founder-led middle...
Wafra’s Minority Investment in Thompson Street
Kirkland & Ellis advised Thompson Street Capital Partners, while Fried, Frank, Harris, Shriver & Jacobson advised on the deal. Thompson Street Capital Partners announced a strategic...
One Equity Partners VIII’s $2.75 Billion Fundraising
Kirkland & Ellis advised One Equity Partners on the deal. One Equity Partners, a middle market private equity firm, announced the closing of One Equity Partners...
MassMutual, Centerbridge Partners and Brown Brothers Harriman’s Launch of Martello Re
Kirkland & Ellis advised Centerbridge Partners and Martello Re Limited on the deal. Martello Re Limited (“Martello Re”), a licensed Class E Bermuda-based life and annuity...
LAV Fund VI and LAV Fund VI Opportunities’ Fundraising
Kirkland advised Lilly Asia Ventures on the deal. Lilly Asia Ventures (LAV) completed the final closing of its sixth USD life sciences funds, LAV Fund VI, L.P. and...